Immunotherapy, Sidedness Strategies Enhancing mCRC Treatment – OncLive
OncLiveImmunotherapy, Sidedness Strategies Enhancing mCRC TreatmentOncLiveCombination immunotherapy has shown great promise in patients with metastatic colorectal cancer (mCRC), specifically in the CheckMate-142 study in which nivolumab (Opdivo) plus i… Continue reading
